EP1309856A2 - Utilisation d'un reseau d'electrodes - Google Patents

Utilisation d'un reseau d'electrodes

Info

Publication number
EP1309856A2
EP1309856A2 EP01919364A EP01919364A EP1309856A2 EP 1309856 A2 EP1309856 A2 EP 1309856A2 EP 01919364 A EP01919364 A EP 01919364A EP 01919364 A EP01919364 A EP 01919364A EP 1309856 A2 EP1309856 A2 EP 1309856A2
Authority
EP
European Patent Office
Prior art keywords
use according
regeneration
examined
electrode array
cultures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01919364A
Other languages
German (de)
English (en)
Inventor
Cornelia Leibrock
Thomas Müller
Hansjürgen VOLKMER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NMI Naturwissenschaftliches und Medizinisches Institut
Original Assignee
NMI Naturwissenschaftliches und Medizinisches Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NMI Naturwissenschaftliches und Medizinisches Institut filed Critical NMI Naturwissenschaftliches und Medizinisches Institut
Publication of EP1309856A2 publication Critical patent/EP1309856A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes

Definitions

  • the present invention is concerned with systems for studying regeneration, synaptogenesis and synaptic stability in biological material, such as cells.
  • the invention is also related to injuries to the central nervous system (CNS) of adult mammals caused, for example, by trauma, ischemia or neurodegenerative diseases. These injuries result in serious and permanent functional deficits that require curative treatment. It is already known that, in contrast to the developing CNS or peripheral nerves, CNS axons lose their ability to regenerate after axotomy at a certain point in development. This loss is believed to result from the non-permessive environment of the CNS and from factors intrinsic to the adult CNS neurons.
  • Treatments that can lead to neural regeneration include the administration of active substances, such as pharmaceuticals, or the use of physical methods, such as electrostimulation.
  • Li et al-, Enthorinal Axons Project to Dentate Gyrus in Organotypic Slice Co-culture, NEUROSCIENCE 1993, Volume 52, pages 799-813 describe an organotypic coculture of the entorhinal cortex and postnatal hippocampus, which prepares itself from its own entorhinal entrance has been.
  • the authors show the formation of entorhinal projections in the cocultivated hippocampus in an immunohistochemical manner, for which the sections were stained and evaluated under a microscope.
  • the authors also show a few electrophysiological data that were obtained with an excitation electrode made of tungsten and a measuring electrode made of glass.
  • the measurement method described here is not suitable as a model system for long-term recordings.
  • WO 00/79273 A2 which was only published after the priority date of the present application, describes a method in which hippocampus tissue is arranged on a microelectrode array, via which the nerve tissue is stimulated and the different response to different psychotropic drugs is measured.
  • the present invention has for its object to provide a way to evaluate treatments that can lead to neural regeneration in a model system that corrects long-term records of physiological activity with morphological changes.
  • This object is achieved according to the invention by using an electrode array in order to investigate a regeneration promoted by active substances or physical processes in biological material, a microelectrode arrangement being preferably used as the electrode arrangement.
  • organotypic cultures and cocultures of tissue of the central nervous system can be used, in particular, for the formation and regeneration of connections to measure functionally between cells and to investigate the effect of pharmaceuticals or physical processes for activating cell functions.
  • promoting regeneration is understood to mean both the effect and the support of regeneration.
  • Electrode arrays especially microelectrode arrays, e.g. Egert et al., A Novel Organotypic Long-term Culture of the Rat Hippocampus on Substrate Integrated Multielectrode Arrays, BRAIN RESEARCH PROTOCOLS, 1998, Volume 2, pages 229-242, are particularly well suited for long-term measurement in such systems ,
  • organotypic cocultures By combining organotypic cocultures with extracellular microelectrode recording technology, the development of new connections and their regenerative ability can be repeatedly monitored on a functional level in the same culture for days to weeks.
  • organotypic cultures represent a good alternative to animal experiments for dealing with questions in the field of regeneration.
  • the coculture model of the dentate gyrus and entorhinal cortex offers a favorable starting point. It can be seen from the literature described in the introduction that this coculture model is well morphologically characterized in the literature, and the analogy to the in vivo situation has also been demonstrated. However, electrophysiological data from the literature are hardly available. bar, these data can now be provided by using the microelectrode array (hereinafter: MEA). It is also advantageous that there is a simple, monosynaptic connection with a clearly defined starting and ending point between the two tissues.
  • MEA microelectrode array
  • the inventors of the present application have now recognized for the first time that the use of microelectrode arrays makes it possible to generate a previously experimentally interrupted perforant pathway both during the juvenile phase, where regeneration is still relatively easy in the central nervous system, and in the differentiated state to investigate.
  • the use of MEA technology in connection with the organotypical culture mentioned as an example offers the possibility of electrophysiologically determining the activity over the entire area of a preparation repeatedly over a period of days and weeks. Electrostimulation at reproducibly always the same places with simultaneous derivation in the entire remaining coculture is also possible in order to prove a connection between the two explants.
  • the explants grow together for the first time in the juvenile phase. If a lesion is then placed through the newly formed connection after the coculture has reached a differentiated state, the regeneration can also be examined in an adult-like state.
  • Such long-term monitoring of 17 derived cocultures on an MEA with electrodes spaced 200 ⁇ m apart and 30 ⁇ m in diameter showed that twelve of these cocultures had grown together again. Seven of these co-cultures that had grown together were lesioned, four of which were still vital after the lesion.
  • the pharmaceuticals or active substances are selected from the group: organic or chemical compounds and biologically active substances, such as peptides, proteins, nucleic acids, where the biological material can include both juvenile cells and cells in an adult-like state.
  • the regeneration of cultures and cocultures can also be observed repeatedly over a longer period of time, preferably more than one week. It is also possible to investigate the reactions of receptor systems to the administration of active substances.
  • the application also relates to a method for investigating the effects of pharmaceuticals on the regeneration potential of functional interconnections in cultures, in which an electrode array is preferably used as described above.
  • FIG. 1 shows a schematic representation of the in vivo situation between the entorhinal cortex (ec) and the dentate gyrus (dg);
  • Figure 3 shows electrical stimulation on cocultures as in Figure 2;
  • Figure 4 shows the restoration of functional compounds in a coculture as in Figure 2.
  • FIG 5 shows the electrical stimulation of electrogenic cells in the cell cluster on an MEA.
  • Example 1 Measurements on a coculture
  • Figure 1 is a schematic drawing of the in vivo situation between the entorhinal cortex (ec) and the dentate gyrus (dg). Part of the perforant pathway is shown with pp, which is cut during the preparation on the dashed line.
  • CA1 and CA3 denote fields of the hippocampus.
  • Sections of the entorhinal cortex and dentate gyrus which were taken from 6 to 7-day-old Wistar rats or BalbC mice, were cultured on a microelectrode array of 60 substrate-integrated electrodes.
  • the electrodes had a stood of 200 ⁇ m and a diameter of 30 ⁇ m.
  • the stimulation of the sections and the recording of the electrophysiological activity was achieved by using an MCS amplifier and a data acquisition system (Multi Channel Systems, Germany), which allows the use of each contact as a stimulation or recording electrode without manipulation of the section allows.
  • the data was recorded online from all 60 channels at a sampling frequency of 25 kHz / channel.
  • FIG. 2 shows such a preparation of the cocultures, for which horizontal brain sections (425 ⁇ m) were used.
  • the entorhinal cortex and the corresponding dentate gyrus were separated from the brain sections, which represent the origin and target tissue of part of the preferant pathway.
  • the cuts that were made during the preparation are shown in dashed lines in FIG. 2a.
  • the two explants were then positioned similar to the in vivo situation on a microelectrode array with an 8x8 field of extracellular electrodes.
  • 2b shows a coculture immediately after preparation.
  • DIV7 Starting from the seventh day in vitro (DIV7), every three days both the total spontaneous activity of the cocultures and the response to extracellular electrical stimulation of layer II of the entorhinal cortex and the stratum granulums of the dentate gyrus were monitored. Additionally marked Dil staining (1, l-dioctadecyl-3, 3, 3, 3-tetramethylindocarbocyanine perchlorate; Honey and Hume, Fluorescent Carbocyanine Dyes Allow Living Neurons of Identified Original to be Studied in Long-term Cultures, J CELL. BIOL. 1986, volume 103, pages 171-187) of the dg retrograd the cells in layer II of the ec.
  • FIG. 3 shows the extracellular stimulation of a coculture of ec and dg
  • FIG. 3a indicating the morphology of the coculture after 7 days in vitro (DIV7)
  • 3b shows the reaction on all MEA electrodes after electrical stimulation in layer II-III of the ec (80 ⁇ A, 150 ⁇ s).
  • FIG. 4 The functional restoration of compounds in cocultivated explants from dg and ec juvenile rats or mice is shown in FIG. 4. After 7 days in vitro, it is possible to elicit activity in the dg via electrical stimulation in the ec (FIG. 4a), but not vice versa (FIG. 4b). This corresponds to the in vivo situation in the ec layer II cells in the dg project.
  • the linked co-culture thus established is now developing in vitro to an adult-like stage, whereupon the newly produced compounds are then damaged.
  • the regenerative potential of the differentiated neurons and the promotion, i.e. effecting or supporting regeneration, of pharmaceuticals or physical processes can then be tested at these lesions.
  • Neuroproductive or regenerative substances that act directly on the output cells in layer II of the ec can enable the pathway that has already been established in vitro to be regenerated, which is normally not possible in the differentiated state.
  • Organotypic cortical cocultures (350-425 ⁇ m thick, from the Neocortex) were prepared from three to seven day old Wistar rats of each sex and maintained in vitro using the roller tube technique; see Gähwiler, Organotypic Monolayer Cultures of Nervous Tissue, J. NEURO-SCIENCE METHODS, 1981, Volume 4, pages 329-342.
  • the cocultures were grown for up to 35 days either on glass coverslips or on microelectrode arrays in medium containing 50% basic Eagle medium, 25% Hanks buffered saline, 25% horse serum, 33 mM D-glucose and 1 mM L-glutamine , The medium was changed twice a week, and the coculture explants were placed with different orientations and distances (0 to 500 ⁇ m) to one another.
  • the explants cultured on glass coverslips were fixed in buffered 4% paraformaldehyde for two hours, washed, treated in buffered 0.1% Triton X-100, washed again and in 1% bovine serum albumin (BSA) and 0.1% Goat serum pre-incubated to prevent non-specific binding.
  • BSA bovine serum albumin
  • the cultures were incubated for 3 to 9 days with primary antibody in 1% buffered BSA solution. After washing for four to five days in buffer, the cultures were incubated with a secondary antibody (goat anti-mouse IgG, CY3) for three to five days and then washed for four to five days. The explants were placed on slides, viewed for fluorescence and photographed. The controls passed Explants that were only incubated with the secondary antibody.
  • Primary antisera (Boehringer, Mannheim) were monoclonal antibodies, which were diluted into working solutions of 0.5 ⁇ g / m and 1 ⁇ g / ml for anti-GAP-43 and synaptophysin.
  • Nissl stains were used to assess the morphology of the explants. The cocultures were fixed, dehydrated, stained in toluidine blue, placed on slides and photographed.
  • the explants cultured on microelectrode arrays were recorded at various times with regard to spontaneous electrical activity, at the earliest after 4 DIV (days in vitro) to at the latest 35 DIV in normal culture medium at a temperature of 35 ° C.
  • the 60 microelectrodes could be recorded simultaneously, which made it possible to test correlated activity in the cocultures.
  • the restoration of functional links between the explants was shown.
  • the electrodes had impedances of 100 to 300 k ⁇ (at 1 kHz), a distance of 500 ⁇ m and a diameter of 10 ⁇ m.
  • the activity was recorded at 10 to 25 kHz per channel, stored and analyzed offline for latency.
  • 5b shows a long-term stimulation over more than one hour, in which uniform responses were obtained on the different electrodes.
  • Each column shows the amplitude of the stimulus response to stimuli that was applied every 60 seconds to the electrode shown with a star.
  • FK506 - an immunosuppressor - that has been shown to have neuroprotective and neuroregenerative effects in the central and peripheral nervous system (Brecht and Herdegen, 1999, The New 'Twist': Inhibition of FKBP Rotamases as a Neuroregenerative and Neuroprotective Principle, Neuro Forum 5: 36-43), was added to the culture medium at 0 DIV in a concentration of 50 nM and administered again with each exchange of the culture medium to 14 DIV. The cocultures were tested for correlated activity and the percentage of explants that showed correlation across an entire group of treated explants was compared to controversies where no explant was treated with the drug.
  • correlated activity is understood to mean the regeneration of functional connections between the sections.

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne l'utilisation d'un réseau d'électrodes afin d'examiner dans un milieu biologique une régénération provoquée par des substances actives ou par des processus physiques.
EP01919364A 2000-03-01 2001-03-01 Utilisation d'un reseau d'electrodes Withdrawn EP1309856A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10009722 2000-03-01
DE10009722 2000-03-01
PCT/EP2001/002332 WO2001065251A2 (fr) 2000-03-01 2001-03-01 Utilisation d'un reseau d'electrodes

Publications (1)

Publication Number Publication Date
EP1309856A2 true EP1309856A2 (fr) 2003-05-14

Family

ID=7632941

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01919364A Withdrawn EP1309856A2 (fr) 2000-03-01 2001-03-01 Utilisation d'un reseau d'electrodes

Country Status (3)

Country Link
US (1) US20030068613A1 (fr)
EP (1) EP1309856A2 (fr)
WO (1) WO2001065251A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010105728A2 (fr) 2009-03-20 2010-09-23 Retina Implant Ag Implant rétinien actif
DE102009015389A1 (de) 2009-03-20 2010-09-30 Retina Implant Ag Aktives Retina-Implantat

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8318488B1 (en) 2004-05-11 2012-11-27 Axiogenesis Ag Assay for drug discovery based on in vitro differentiated cells
US9199080B2 (en) 2011-09-12 2015-12-01 Okuvision Gmbh Method for treating an eye

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593852A (en) * 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5187096A (en) * 1991-08-08 1993-02-16 Rensselaer Polytechnic Institute Cell substrate electrical impedance sensor with multiple electrode array
US5432086A (en) * 1992-11-18 1995-07-11 Sy-Lab Vertriebsgellschaft M.B.H. Apparatus for the automatic monitoring of microorganism culture
US6169394B1 (en) * 1998-09-18 2001-01-02 University Of The Utah Research Foundation Electrical detector for micro-analysis systems

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0165251A3 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010105728A2 (fr) 2009-03-20 2010-09-23 Retina Implant Ag Implant rétinien actif
DE102009015389A1 (de) 2009-03-20 2010-09-30 Retina Implant Ag Aktives Retina-Implantat
DE102009061008A1 (de) 2009-03-20 2011-07-14 Retina Implant AG, 72770 Testvorrichtung für Zellen, Zellkulturen und/oder organotypische Zellverbände
DE102009061008B4 (de) * 2009-03-20 2014-09-25 Retina Implant Ag Verwendung einer Testvorrichtung und Verfahren zum Test von Zellen, Zellkulturen und/oder organotypischen Zellverbänden

Also Published As

Publication number Publication date
WO2001065251A2 (fr) 2001-09-07
WO2001065251A3 (fr) 2003-03-13
US20030068613A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
Grosche et al. Microdomains for neuron–glia interaction: parallel fiber signaling to Bergmann glial cells
Moga et al. Activity-regulated cytoskeletal-associated protein is localized to recently activated excitatory synapses
Stett et al. Biological application of microelectrode arrays in drug discovery and basic research
Bray et al. The use of peripheral nerve grafts to enhance neuronal survival, promote growth and permit terminal reconnections in the central nervous system of adult rats
Bakkum et al. Tracking axonal action potential propagation on a high-density microelectrode array across hundreds of sites
WO2015135893A1 (fr) Obtention de cultures neuronales spécifiques à une région cérébrale à partir de cultures tissulaires tridimensionnelles de cellules souches
DE60220947T2 (de) Vorrichtung zur stimulierung einer tierischen zelle und zur aufzeichnung ihres physiologischen signals sowie herstellung davon und verwendungsverfahren dafür
Alstermark et al. Transneuronal transport of wheat germ agglutinin conjugated horseradish peroxidase into last order spinal interneurones projecting to acromio-and spinodeltoideus motoneurones in the cat: 1. Location of labelled interneurones and influence of synaptic activity on the transneuronal transport
Naruo et al. Sevoflurane blocks cholinergic synaptic transmission postsynaptically but does not affect short-term potentiation
Kano et al. Innervation and acetylcholine sensitivity of skeletal muscle cells differentiatedin vitro from chick embryo
WO2001065251A2 (fr) Utilisation d'un reseau d'electrodes
Frosch et al. Physiology and pharmacology of olfactory bulb neurons in dissociated cell culture
DE69030003T2 (de) Mikroelektroden und deren anwendung in elektrochemischen stromkreisen mit telemetrischer übertragung
Askanas et al. Glucocorticoid increases acetylcholinesterase and organization of the postsynaptic membrane in innervated cultured human muscle
EP1210109A2 (fr) Utilisation d'au moins un inhibiteur d'aminopeptidase
DE60117180T2 (de) Verfahren zur messung des aktivierungszustands von signalwegen in zellen
Markstein Bedeutung neuer Dopaminrezeptoren für die Wirkung von Clozapin
DE102014003432B3 (de) Verfahren zum Testen neuroaktiver Substanzen
DE19932720C2 (de) Verfahren zur Messung der Wirkung von Stoffen auf die Erregbarkeit zentralnervöser Zellen oder Zellverbände
WO2002016936A1 (fr) Dispositif et procede d'etude a resolution locale de cellules et/ou de systemes cellulaires reticules et utilisation pour l'etude d'agents actifs au moyen d'un microphysiometre
EP1402258A2 (fr) Procede pour determiner des interactions entre des keratinocytes et des neurones
DE102016223423B4 (de) Verfahren, Vorrichtung und Kit zur Bestimmung der kardialen Erregungsleitung
Masi et al. Multielectrode array: A new approach to plant electrophysiology
Egert Network on chips
EP1407263B1 (fr) Procede de detection extracorporelle qualitative et/ou quantitative de substances neurotoxiques dans le plasma sanguin d'un individu

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020921

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LEIBROCK, CORNELIA

Inventor name: VOLKMER, HANSJUERGEN

Inventor name: MUELLER, THOMAS

17Q First examination report despatched

Effective date: 20030818

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051001